bulk RNAseq of Ccd18-Co cell line treated with cytokines
RNA-seq (gene expression) · human · 44 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 44 samples: 10 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE307526_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1321922 and SRA study SRP618482. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 40 samples.
How we read this: 10 replicated groups read from 44 sample titles; they account for 40 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9225994 unstimulated 1.
- GSM9225995 unstimulated 2.
- GSM9225996 unstimulated 3.
- GSM9225997 unstimulated 4.
- GSM9225998 IL1B 1 IL1B
- GSM9225999 IL1B 2 IL1B
- GSM9226000 IL1B 3 IL1B
- GSM9226001 IL1B 4 IL1B
- GSM9226002 IL6 1 IL6
- GSM9226003 IL6 2 IL6
- GSM9226004 IL6 3 IL6
- GSM9226005 IL6 4 IL6
- GSM9226006 IL13 1 IL13
- GSM9226007 IL13 2 IL13
- GSM9226008 IL13 3 IL13
- GSM9226009 IL13 4 IL13
- GSM9226010 IL17A 1 IL17A
- GSM9226011 IL17A 2 IL17A
- GSM9226012 IL17A 3 IL17A
- GSM9226013 IL17A 4 IL17A
- GSM9226014 IL22 1 IL22
- GSM9226015 IL22 2 IL22
- GSM9226016 IL22 3 IL22
- GSM9226017 IL22 4 IL22
- GSM9226018 IFNA 1 IFNA
- GSM9226019 IFNA 2 IFNA
- GSM9226020 IFNA 3 IFNA
- GSM9226021 IFNA 4 IFNA
- GSM9226022 IFNG 1 IFNG
- GSM9226023 IFNG 2 IFNG
- GSM9226024 IFNG 3 IFNG
- GSM9226025 IFNG 4 IFNG
- GSM9226026 TGFB1 1 TGFB1
- GSM9226027 TGFB1 2 TGFB1
- GSM9226028 TGFB1 3 TGFB1
- GSM9226029 TGFB1 4 TGFB1
- GSM9226030 TNF 1 TNF
- GSM9226031 TNF 2 TNF
- GSM9226032 TNF 3 TNF
- GSM9226033 TNF 4 TNF
+ 4 more — browse all 44 samples with per-sample file links →
- GSE307519 bulk RNAseq of Ccd18-Co cell line treated with cytokine mix and/or epigenetic modulator 16 samples shares ccd18-co, treated, bulk, line
- GSE269374 Microprotein-Encoding RNA Regulation in Cells Treated with Pro-inflammatory and Pro-Fibrotic Stimuli (RNA-Seq colon cell lines) 54 samples shares treated, line
- GSE263588 Comprehensive transcriptomic profiling of glioblastoma patient-derived primary tumor cell lines using bulk RNA-sequencing 49 samples shares bulk, line
- GSE303762 Benchmarking long-read RNA-sequencing technologies with LongBench: a cross-platform reference dataset profiling cancer cell lines with bulk and single-cell approaches 38 samples shares bulk, line
- GSE254323 RNA-seq of colorectal cancer cell line HCT116 and DLD-1 cells treated with PRIMA-1met or oxaliplatin or combination therapy 24 samples shares treated, line
- GSE289582 Baseline tumor features and peripheral blood immune dynamics that underlie efficacy in MSS metastatic colorectal cancer treated with regorafenib, ipilimumab, and nivolumab [Blood] 115 samples shares treated, line
- GSE272346 Late-stage tertiary lymphoid structures in hepatocellular carcinoma treated with neoadjuvant immune checkpoint blockade [bulk RNA-seq] 14 samples shares treated, bulk
- GSE253493 RNA-Seq experiment of primary hepatic stellate cells (HSCs) and LX-2 cell line treated with TGFb 12 samples shares treated, line
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.